ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ELDN Eledon Pharmaceuticals Inc

2.205
-0.235 (-9.63%)
Last Updated: 03:29:36
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Eledon Pharmaceuticals Inc ELDN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.235 -9.63% 2.205 03:29:36
Open Price Low Price High Price Close Price Previous Close
2.15 2.11 2.23 2.44
more quote information »

Recent News

Date Time Source Heading
07/5/202421:15EDGAR2Form 8-K - Current report
07/5/202421:05GLOBEEledon Announces Clinical Progress with Tegoprubart in the..
07/5/202421:00GLOBEEledon Pharmaceuticals Announces Oversubscribed $50 Million..
29/3/202407:01GLOBEEledon Pharmaceuticals Reports Fourth Quarter and Full Year..
26/3/202407:56GLOBEEledon Pharmaceuticals Announces 12th Participant Enrolled..
22/3/202401:31GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart in..
15/2/202407:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/2/202407:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202411:01GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202408:40GLOBEEledon Pharmaceuticals Highlights Recent Business Milestones..
05/12/202310:00GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
30/11/202308:05GLOBEEledon Pharmaceuticals to Present at Noble Capital Markets'..
10/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:01GLOBEEledon Pharmaceuticals Reports Third Quarter 2023 Operating..
09/11/202308:05GLOBEEledon Pharmaceuticals to Present at Jefferies London..
03/11/202307:30EDGAR2Form 8-K - Current report
03/11/202300:05GLOBEEledon Reports Updated Data from Ongoing Phase 1b Trial..
23/10/202322:00GLOBEEledon Pharmaceuticals Strengthens Leadership Team with..
13/10/202322:00GLOBEEledon Pharmaceuticals to Present Data from Ongoing Phase 1b..
04/10/202307:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202307:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202308:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/10/202308:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202322:30EDGAR2Form 8-K - Current report
02/10/202322:00GLOBEEledon Pharmaceuticals Appoints Kidney Transplant Specialist..
25/9/202321:00GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart..
21/9/202306:05GLOBEEledon Pharmaceuticals to Participate at the 2023 Cantor..
14/9/202306:42EDGAR2Form 8-K - Current report
11/9/202321:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
06/9/202321:00GLOBEEledon Pharmaceuticals Announces Publication of Data Showing..
05/9/202321:00GLOBEEledon Pharmaceuticals Announces First Participant Dosed in..
16/8/202321:00GLOBEEledon Pharmaceuticals Announces Dosing of 10th Patient in..
11/8/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202321:05EDGAR2Form 8-K - Current report
10/8/202321:00GLOBEEledon Pharmaceuticals Reports Second Quarter 2023 Operating..
02/6/202322:00GLOBEEledon Pharmaceuticals to Present at Jefferies Healthcare..
12/5/202306:01GLOBEEledon Pharmaceuticals Reports First Quarter 2023 Operating..

Your Recent History

Delayed Upgrade Clock